InCube Labs, L.L.C. - Feb 3, 2022 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
10%+ Owner
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Mir Imran, President of InCube Labs, LLC
Stock symbol
RANI
Transactions as of
Feb 3, 2022
Transactions value $
$0
Form type
4
Date filed
2/7/2022, 08:36 PM
Previous filing
Aug 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Other $0 +13.9K $0.00 13.9K Feb 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in kind pro rata distribution from Biologix Partners, LP (3,181 shares of Class A Common Stock) and VH Rani, LP. (10,742 shares of Class A Common Stock), to its limited partners.